Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

April 15, 2025 BioData Solutions

Can volumetric absorptive microsampling (VAMS) deliver reliable quantitative bioanalysis from just a small volume of human whole blood?

This collaborative study from KCAS Bio, BioData Solutions, and Gates MRI explores the development and optimization of a quantitative ligand-binding assay using VAMS for an investigational anti-malarial monoclonal antibody. Discover the analytical considerations, challenges, and findings that could help advance more patient-centric approaches to bioanalytical sample collection. Download the poster developed in collaboration with Gates Medical Research Institute and KCAS Bio to learn more.

Videos

Overview of Anti-Drug Antibody (ADA) and Neutralizing Antibodies (NAb) Risk Assessments | Mini-Learning

Overview of Anti-Drug Antibody (ADA) and Neutralizing Antibodies (NAb) Risk Assessments | Mini-Learning

May 11, 2026

Immunogenicity Risk Assessment – Finding Data from Similar Molecules | Mini-Learning

Immunogenicity Risk Assessment – Finding Data from Similar Molecules | Mini-Learning

May 9, 2026

How to Write Controlled Documents for Your Lab | Mini-Learning

How to Write Controlled Documents for Your Lab | Mini-Learning

May 8, 2026

Immunogenicity Risk Assessment – Main Components | Micro-Learning

Immunogenicity Risk Assessment – Main Components | Micro-Learning

May 7, 2026

Bioanalytical Components of INDs, NDAs, and BLAs | Mini-Learning

Bioanalytical Components of INDs, NDAs, and BLAs | Mini-Learning

March 17, 2026

Requirements for IND vs NDA/BLA | Micro-Learning

Requirements for IND vs NDA/BLA | Micro-Learning

November 11, 2025

App Notes

Cross-Validation of Statistical Workflow for Cut Point Calculation using Red Thread (Python) Vs R

September 17, 2024

Comparing Cut Points Between Statistical Software Stata and R Using Random Effects Model

September 17, 2024

Videos

Turning a Potential BLA Crisis Into Compliance Success: BioData’s Evidence Backed ADA Strategy Wins Regulatory Approval

March 4, 2026

Simplifying Bioanalytical Review Using Advanced Computational Techniques

September 17, 2024

Posters

Development and Optimization of a Quantitative Assay for an Investigational Anti-Malarial Monoclonal Antibody Drug Candidate in Human Whole Blood Using Volumetric Absorptive Microsampling (VAMS)

April 15, 2025

Assessing the Impact of Ultra-Low Cut Points in Immunogenicity Assays

December 2, 2024

Singlet Analysis Yields Equivalent Results as Duplicate Analysis in Preclinical Immunogenicity Assessment

September 17, 2024

Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis

September 17, 2024

White Papers

Artificial Intelligence increases efficiencies and reduces bias for bioanalytical pharmacokinetic studies and anti-drug antibody statistical determinations

September 17, 2024